| Brand Name: RISPERDAL Generic Name: Risperidone Drug Class: TRANQUILIZERS
INDICATIONS
Bipolar Mania
Combination Therapy
Efficacyy Generic RISPERDAL (Risperidone) in a combination with lithium or valproate has been spent at one controlled placebo (3-week) experiment with the patients meeting criteria DSM IV for Bipolar I.
Combination Generic RISPERDAL (Risperidone) with lithium or valproate is designated for short-lived processing the acute mad or blended episodes connected with Bipolar I Disorder.
Monotherapy
Efficacyy Generic RISPERDAL (Risperidone) has been spent at two controlled placebo tests (3-week) with the patients meeting criteria DSM IV for Bipolar I.
Generic RISPERDAL (Risperidone) it is designated for short-lived processing the acute mad or blended episodes connected with Bipolar I Disorder.
Schizophrenia
Efficacyy Generic RISPERDAL (Risperidone) in a schizophrenia has been spent in short-lived (6-8 weeks) controlled tests of inpatients of the schizophrenic.
Generic RISPERDAL (Risperidone) it is designated for processing schizophrenias.
ADMINISTRATION & DOSAGE
Bipolar Mania
Dosage in Special Populations
In some patients, more sluggish titration can be conforming from the medical point of view. Augmentations of dosage in these patients should be in increments no more, than BID on 0.5 mg. Augmentations to dosages described above BID on 1.5 mg should meet in general interspaces in at least 1 week. A recommended initial dose - BID on 0.5 mg at patients who, patients with serious renal or liver damage, and patients or predisposed to a hypotonia or for whom the hypotonia would arrange risk are elderly or exhausted.
Pediatric Use
Safety and efficacyy Generic RISPERDAL (Risperidone) in pediatric patients with a schizophrenia or an acute mania have contacted Bipolar I, disorder has not been spent.
Maintenance Therapy
While in general it is accepted, that pharmacological processing outside of acute reaction in a mania is desirable, and for maintenance of initial reaction and for an avoidance of new mad episodes, there are no regularly received data to support utilization risperidone on such long-term processing (that is, outside of 3 weeks). There is no body of the evidence, available from controlled tests that messages of the clinical doctor in long-term control of the patient who, is enriched during processing an acute mad episode with risperidone.
Usual Dose
In tests, short-lived (3 weeks) antimad efficacyy has been shown in a nonrigid range of dosage of 1-6 mg day. Generic RISPERDAL (Risperidone) doses above, than 6 mg day have not been investigated. Adjustment of dosage if it is designated, should meet interspaces at not less than 24 o'clock and in increments / decrements of dosage of 1 mg day as it is investigated in short-lived, controlled placebo tests. Risperidone the plan, beginning with 2 mg to 3 mg day should be applied on once daily.
Schizophrenia
Maintenance Therapy
Patients should be overestimated periodically to define need of processing maintenances with the conforming dose. On experiment, Generic RISPERDAL (Risperidone) it was applied on the plan QD, in 1 mg QD pristinely, with augmentations to 2 mg QD in the second day, and to a target dose of 4 mg QD in the third day. While there is no body of the evidence, available to reply to how for a long time the patient of the schizophrenic, with Generic RISPERDAL (Risperidone) should remain on it, efficacyy Generic RISPERDAL (Risperidone) of 2 mg / days by 8 mg / days in a late relapse has been shown on controlled experiment at patients who, was clinically stable within at least 4 weeks and then followed for the period of 1 - 2 years.
Usual Initial Dose
Safety of doses 16 mg / days described above has not been estimated on clinical experiments. Doses 6 mg / days described above for dosing BID have not been shown to be more efficient than lower doses, have been connected to a plenty extrapyramidal signs and other adverse effects, and at all are not recommended. In the only thing the studying bolstering QD dosing, results of efficacyy in general were stronger for 8 mg than for 4 mg. Efficacyy in a schizophrenia has been shown in a range of a dose 4 to16 mg / days on the clinical experiments bolstering efficacyy Generic RISPERDAL (Risperidone); however, the maximal effect in general saw in a range 4 - 8 mg / days.
Co-Administration of Generic RISPERDAL (Risperidone) with Certain Other Medications
The dose risperidone requires to be titrated accordingly for the patients receiving these inducers of an enzyme, is especial during initiation or the arrest of therapy with these inducers. Collateral purpose carbamazepine and other inducers of an enzyme (for example, Phenytoinum, rifampin, phenobarbital) with risperidone, predictably, will cause decreases by plasma concentrations an awake half (the sum risperidone and 9-hydroxyrisperidone) which lead to the reduced efficacyy risperidone processings could. | 
